ABLYNX PROMOTED TO THE BELGIAN MID-CAP INDEX>

ABLYNX PROMOTED TO THE BELGIAN MID-CAP INDEX

(Thomson Reuters ONE) - GHENT, Belgium, 2 July 2009 - Ablynx [Euronext Brussels: ABLX], apioneer in the discovery and development of Nanobodies®, a novelclass of antibody-derived therapeutic proteins, announced today itspromotion to the Belgian Mid-Cap Index (Bel Mid Index or BELMID) from1 July 2009.The entry of Ablynx to the Bel Mid Index is dependent upon Ablynx'smarket capitalization, free float and velocity.Dr. Edwin Moses, Chief Executive Officer and Chairman of Ablynxcommented: "The promotion of Ablynx to the Bel Mid Index is atestament to the considerable progress Ablynx has made since our IPO.We have a strong cash position and the financial turmoil over thelast year has not directly negatively affected Ablynx. We continue tobuild and diversify our shareholder base, both domestically andinternationally. There are now three Nanobodies® in clinicaldevelopment and our lead programme, ALX-0081, a novelanti-thrombotic, is on track to initiate Phase II during Q3. Earlierthis week, we announced that ALX-0061, our novel Nanobody® -basedtherapeutic programme against IL6R, has entered preclinicaldevelopment for the treatment of autoimmune and inflammatorydiseases." Dr Moses added: "Our diverse product portfolio illustratesthe breadth of work across several therapeutic areas which is beingundertaken to exploit the significant potential of our Nanobody®platform." -ends-For more information, please contact:For international media enquiries: College Hill Life SciencesSue Charles, Justine Lamond,Dr. John McIntyret: +44 (0)20 7866 7857e: ablynx(at)collegehill.comAblynx:Dr. Edwin MosesChairman and CEOt: +32 (0)9 262 00 07m: +44 (0)7771 954 193 / +32 (0)473 39 50 68e: edwin.moses(at)ablynx.comEva-Lotta AllanChief Business Officert: +32 (0)9 262 00 75m: +32 (0)475 78 36 21 / +44 (0)7990 570 900e: eva-lotta.allan(at)ablynx.comhttp://hugin.info/137912/R/1326978/312528.pdfThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
Datum: 02.07.2009 - 22:35 Uhr
Sprache: Deutsch
News-ID 3203
Anzahl Zeichen: 0

contact information:
Town:

London

Kategorie:

Business News

Diese Pressemitteilung wurde bisher 256 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"ABLYNX PROMOTED TO THE BELGIAN MID-CAP INDEX>"
steht unter der journalistisch-redaktionellen Verantwortung von

Ablynx (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Publication in Accordance With Article 14 of the Belgian Law of 2 May 2007 Regar ...

GHENT, BELGIUM -- (Marketwired) -- 08/27/13 -- (EURONEXT BRUSSELS: ABLX) today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to tr ...

Ablynx Announces Half-Year Results for 2013 ...

GHENT, BELGIUM -- (Marketwired) -- 08/21/13 -- (EURONEXT BRUSSELS: ABLX) today announced its results for the six-month period ending 30 June 2013, which have been prepared in accordance with the IAS 34 "Interim Financial Reporting" as adop ...

Ablynx Announces Warrant Exercise ...

GHENT, BELGIUM -- (Marketwired) -- 07/23/13 -- (EURONEXT BRUSSELS: ABLX) today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14 February 2008, that an additional 273,913 common shares have been issued by the ...

Alle Meldungen von Ablynx